FR2582001B2 - Nouveaux derives de l'a1-antitrypsine humaine, composition et reactif biologique les contenant - Google Patents

Nouveaux derives de l'a1-antitrypsine humaine, composition et reactif biologique les contenant

Info

Publication number
FR2582001B2
FR2582001B2 FR8507393A FR8507393A FR2582001B2 FR 2582001 B2 FR2582001 B2 FR 2582001B2 FR 8507393 A FR8507393 A FR 8507393A FR 8507393 A FR8507393 A FR 8507393A FR 2582001 B2 FR2582001 B2 FR 2582001B2
Authority
FR
France
Prior art keywords
antitrypsin
derivatives
composition
reagent containing
novel human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8507393A
Other languages
English (en)
Other versions
FR2582001A2 (fr
Inventor
Michael Courtney
Sophie Jallat
Luc-Henri Tessier
Jean-Pierre Lecocq
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR8507393A priority Critical patent/FR2582001B2/fr
Application filed by Transgene SA filed Critical Transgene SA
Priority to EP85401207A priority patent/EP0169114B1/fr
Priority to DE8585401207T priority patent/DE3581328D1/de
Priority to PCT/FR1985/000158 priority patent/WO1986000337A1/fr
Priority to AT85401207T priority patent/ATE60088T1/de
Priority to JP60502680A priority patent/JP2599585B2/ja
Priority to CA000484504A priority patent/CA1341216C/fr
Priority to DK076286A priority patent/DK171064B1/da
Publication of FR2582001A2 publication Critical patent/FR2582001A2/fr
Application granted granted Critical
Publication of FR2582001B2 publication Critical patent/FR2582001B2/fr
Priority to US07/967,576 priority patent/US6072029A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR8507393A 1984-06-19 1985-05-15 Nouveaux derives de l'a1-antitrypsine humaine, composition et reactif biologique les contenant Expired FR2582001B2 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR8507393A FR2582001B2 (fr) 1985-05-15 1985-05-15 Nouveaux derives de l'a1-antitrypsine humaine, composition et reactif biologique les contenant
DE8585401207T DE3581328D1 (de) 1984-06-19 1985-06-18 Derivate des menschlichen alpha-1-antitrypins und verfahren zu deren herstellung.
PCT/FR1985/000158 WO1986000337A1 (fr) 1984-06-19 1985-06-18 DERIVES DE L'alpha1-ANTITRYPSINE HUMAINE ET PROCEDE POUR LEUR PREPARATION
AT85401207T ATE60088T1 (de) 1984-06-19 1985-06-18 Derivate des menschlichen alpha-1-antitrypins und verfahren zu deren herstellung.
EP85401207A EP0169114B1 (fr) 1984-06-19 1985-06-18 Dérivés de l'alpha 1-antitrypsine humaine et procédé pour leur préparation
JP60502680A JP2599585B2 (ja) 1984-06-19 1985-06-18 ヒトα▲下１▼−アンチトリプシン誘導体及びその製造法
CA000484504A CA1341216C (fr) 1984-06-19 1985-06-19 Derives de l'.alpha.-1-antitrypsine humaine et procede pour leur preparation
DK076286A DK171064B1 (da) 1984-06-19 1986-02-18 Analoger af humant alfa1-antitrypsin, fremgangsmåde til fremstilling deraf, lægemiddel indeholdende analogerne, biologisk reagens indeholdende analogerne, samt anvendelse af analogerne
US07/967,576 US6072029A (en) 1984-06-19 1992-10-27 Derivatives of human α1 -antitrypsin and process for their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8507393A FR2582001B2 (fr) 1985-05-15 1985-05-15 Nouveaux derives de l'a1-antitrypsine humaine, composition et reactif biologique les contenant

Publications (2)

Publication Number Publication Date
FR2582001A2 FR2582001A2 (fr) 1986-11-21
FR2582001B2 true FR2582001B2 (fr) 1988-04-29

Family

ID=9319316

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8507393A Expired FR2582001B2 (fr) 1984-06-19 1985-05-15 Nouveaux derives de l'a1-antitrypsine humaine, composition et reactif biologique les contenant

Country Status (1)

Country Link
FR (1) FR2582001B2 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU577259B2 (en) * 1982-08-13 1988-09-22 Zymogenetics Inc. Glycolytic promters for regulated protein expression protease inhibitor
BE895961A (fr) * 1983-02-21 1983-06-16 Wallone Region Procede de preparation d'un clone bacterien produisant de 1'alpha 1-antitrypsine humaine

Also Published As

Publication number Publication date
FR2582001A2 (fr) 1986-11-21

Similar Documents

Publication Publication Date Title
FR2612516B1 (fr) Derives de benzoxazole et preparation les contenant
FR2602974B1 (fr) Composition pharmaceutique contenant de la nicotine ou ses derives
FR2586562B1 (fr) Composition pharmaceutique contenant de l'a-methylhistamine
DK205287D0 (da) Bioklaebemidler til celle- og vaevsklaebning
FR2580277B1 (fr) Nouveaux derives naphtaleniques a action retinoique, le ur procede de preparation et compositions medicamenteuse et cosmetique les contenant
PT78340B (fr) Procede de preparation de nouveaux derives de la tetrahydroxy- 3',4',5,7-flavone et des compositions pharmaceutiques les contenant
FR2626002B1 (fr) Nucleosides dideoxydidehydrocarbocycliques et composition pharmaceutique les contenant
FR2645152B1 (fr) 3h-pteridinones-4, procedes de preparation et medicaments les contenant
DE68929060T2 (de) Synthese von 1,2-Dioxetanen und Zwischenprodukte dafür
ES2015571B3 (es) Concentracion de extracto de ostras descolorido.
FR2607502B1 (fr) Derives de l'imidazole, leur preparation et compositions medicamenteuses les contenant
FR2626175B1 (fr) Composes nouveaux de 1,2-ethylenediamine et composition pharmaceutique les contenant
FR2608921B1 (fr) Composition pharmaceutique contenant de la ranitidine
MC1847A1 (fr) Fragments d'interferons imnuns recombinants,homogenes et composition pharmaceutiques les contenant
FR2594847B1 (fr) Procede de preparation de polypeptides biologiquement actifs, polypeptides obtenus et compositions les contenant
FR2556720B1 (fr) Derives de l'amidine et tonicardiaques les contenant
FR2605004B1 (fr) Nouveaux derives d'amino-acides, leur procede de preparation et composition pharmaceutiques les contenant
FR2446819B1 (fr) Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant
PT80111A (fr) Procede de preparation de nouveaux arylthio-pyridinyl-alcanole et de compositions fongicides les contenant
FI891138A0 (fi) Anordning foer kontinuerlig biologisk nedbrytning av mineraler och mineralkoncentrat.
FR2582001B2 (fr) Nouveaux derives de l'a1-antitrypsine humaine, composition et reactif biologique les contenant
FR2528425B1 (fr) 1,4-dihydropyridines et composition pharmaceutique les contenant
FR2609033B1 (fr) Derives de la pyrimidine, leur preparation et compositions les contenant
FR2592883B1 (fr) Derives de vinblastine et composition pharmaceutique les contenant
FR2595698B1 (fr) Composes de pyrone-3-carboxamide et composition herbicide les contenant